Status:

COMPLETED

Real-world Effect of Switching From Intermittently-scanned to Real-time Continuous Glucose Monitoring (Switch CGM Retro)

Lead Sponsor:

LMC Diabetes & Endocrinology Ltd.

Collaborating Sponsors:

DexCom, Inc.

Conditions:

Diabetes Mellitus

Eligibility:

All Genders

18+ years

Brief Summary

The objective of this retrospective, observational study, is to better understand the real-world glycemic effectiveness of switching to real time continuous glucose monitoring (rtCGM) from intermitten...

Eligibility Criteria

Inclusion

  • 18 years or older as of the index date
  • Clinical diagnosis of T1D or T2D ≥ one year
  • Using either MDI or CSII therapy
  • Initiated a FreeStyle Libre® isCGM device between January 1, 2018 and July 31, 2023 (isCGM cohort)
  • Switched from a FreeStyle Libre® 1 or Libre 2® isCGM device to a Dexcom® G5 or G6 CGM device between April 1, 2018 and July 31, 2023 (rtCGM cohort)
  • Baseline HbA1c ≥7.0% for primary objective with rtCGM cohort
  • Baseline HbA1c ≥8.0% for key secondary objective comparing rtCGM cohort to isCGM cohort
  • Known rtCGM/isCGM start date (month and year)
  • Exclusive use of isCGM for ≥ 3 months
  • ≥ one HbA1c value up to 6 months (± 6 weeks) prior to index date (HbA1c value must be after isCGM initiation and no more than 6 weeks after the index date)
  • ≥ one HbA1c value 6-12 months (± 6 weeks) following the index date
  • Informed consent for their medical record data to be used for research purposes

Exclusion

  • Have a prior history of rtCGM within 12 months of the index date
  • Are pregnant at the time of isCGM initiation or time of switch to rtCGM
  • Used the isCGM or rtCGM for \< 3 months

Key Trial Info

Start Date :

January 25 2024

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 29 2024

Estimated Enrollment :

220 Patients enrolled

Trial Details

Trial ID

NCT06962735

Start Date

January 25 2024

End Date

August 29 2024

Last Update

May 11 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

LMC Diabetes & Endocrinology Ltd.

Toronto, Ontario, Canada, M4G3E8